7 September 2012

BluGlass awaits patent and proposes to buyout JV partner

BluGlass Ltd of Silverwater, Australia says that its patent US2008272463 ‘Method and apparatus for growing a group (III) metal nitride film’ has been allowed in the US. Once granted in the next few weeks, the patent will bring BluGlass’ total number of granted patents in the US, Europe Japan, Korea and China to sixteen.

The firm adds that its patents provide broad protection for its Remote Plasma Chemical Vapour Deposition (RPCVD) technology, and underpin the commercial opportunities for BluGlass related to LED and solar cell manufacturing markets.

“We are pleased that we have had another core patent accepted in the US which will further help to protect BluGlass’ technology assets enabling the company to continue its move towards commercialising the RPCVD technology.”

BluGlass has also recently lodged two additional patents through its joint venture, EpiBlu.  In a separate statement regarding EpiBlu, BluGlass has proposed a capital restructure to its shareholders, which involves purchasing all the shares in EpiBlu held by its joint venture partner SPTS Technologies Ltd of Newport, Wales, UK. The proposal is for the issue of 15,973,678 fully paid ordinary shares (“Subscription Shares”) in the capital of BluGlass to SPTS, which equates to 5% of BluGlass’ enlarged share capital.

See related items:

BluGlass and SPTS JV establishing RPCVD research and demonstration site in UK

SPTS invests AUS$5.2m for 19.9% stake in BluGlass

Tags: BluGlass SPTS RPCVD LEDs Solar cells GaN

Visit: www.spp-pts.com

Visit: www.bluglass.com.au